Home
Live Updates
Autolus Therapeutics announces the appointment of Robert W. Azelby to its Board of Directors : vimarsana.com
Autolus Therapeutics announces the appointment of Robert W. Azelby to its Board of Directors
LONDON, Jan. 10, 2024 -- Autolus Therapeutics plc , a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced the appointment of Robert W....
Related Keywords
London ,
City Of ,
United Kingdom ,
Lauren Williams ,
Robertw Azelby ,
Bob Azelby ,
Susana Noonan ,
Julia Wilson ,
Alder Biopharmaceuticals Inc ,
Sa Noonan Communications ,
Cascadian Therapeutics Inc ,
Juno Therapeutics Inc ,
Immunomedics Inc ,
Nasdaq ,
Amgen ,
Clovis Oncology Inc ,
Harvard Business School ,
Management Team ,
Eliem Therapeutics Inc ,
Exchange Commission ,
University Of Virginia ,
Board Of Directors Chinook Therapeutics Inc ,
Exchange Commission On ,
Autolus Board ,
Christian Itin ,
Chief Executive Officer ,
Eliem Therapeutics ,
Alder Biopharmaceuticals ,
Executive Vice President ,
Chief Commercial Officer ,
Juno Therapeutics ,
Vice President ,
General Manager ,
Amgen Oncology ,
Oncology Sales ,
Commercial Effectiveness Unit ,
Chinook Therapeutics Inc ,
Cascadian Therapeutics ,
Religious Studies ,
Harvard Business ,
Autolus Therapeutics ,
Private Securities Litigation Reform Act ,
Autolu Annual Report ,
Markets ,
vimarsana.com © 2020. All Rights Reserved.